Reps. Rosa DeLauro, D-Conn., and Nita Lowey, D-N.Y., introduced legislation that would mandate registration with the FDA by drug compounders. The Supporting Access to Formulated and Effective Compounded Drugs Act would create an FDA database for use by federal and state regulators in the oversight of compounding pharmacies, but the bill is not expected to be voted on by the end of this session. On Dec. 19, state and FDA officials will meet to discuss states' current authority to regulate compounders.